Skip to content
Antibodies & Bispecifics
Antibody Platforms
Monoclonal Discovery
Bispecific Discovery
Optimization
TCR Mimics
Genetic Medicines
Cell Therapies
Partnering
Ecosystem Allies
About
Leadership
News and Events
Careers
Resources
Antibodies & Bispecifics
Antibody Platforms
Monoclonal Discovery
Bispecific Discovery
Optimization
TCR Mimics
Genetic Medicines
Cell Therapies
Partnering
Ecosystem Allies
About
Leadership
News and Events
Careers
Resources
Contact Us
Full resource library
Alloy Therapeutics resources all in one place
Modality
Solution
Type
Modality
Antibodies and Bispecifics
Cell Therapies
Genetic Medicines
TCR Mimics
Solution
Antibody Platforms
Bispecific Discovery
Monoclonal Discovery
Optimization
TCR Mimic
Type
Case Studies
Perspectives
Press Releases
Technical Notes
Webinars
Press Releases
Alloy Therapeutics Signs Memorandum of Understanding (MOU) with the Republic of Serbia to Support Global Bioeconomy Initiative
Learn more
Press Releases
米アロイ・セラピューティクス、 湘南ヘルスイノベーションパークに新拠点を設立
Learn more
Press Releases
Alloy Therapeutics enters Japanese market by establishing operations at Shonan Health Innovation Park
Learn more
Webinars
Discover TCR mimic antibodies that Target Previously “Undruggable” Intracellular Proteins with Keyway™ TCR
Learn more
Webinars
Accelerating Bispecific Discovery with the Alloy Common Light Chain Platform
Learn more
Webinars
Accelerating Therapeutic Discovery: ATX-Gx™ Human, Transgenic Platform
Learn more
Technical Notes
High Velocity AI-Enabled and ML-Powered Therapeutic Antibody Discovery
Learn more
Technical Notes
Highly Specific anti-WT1/HLA-A2 TCRm Antibodies
Learn more
Perspectives
How AI is reshaping antibody discovery and optimization workflows
Learn more
